4//SEC Filing
Weinberg Jonathan 4
Accession 0001628908-25-000105
CIK 0001628908other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 7:10 AM ET
Size
5.8 KB
Accession
0001628908-25-000105
Insider Transaction Report
Form 4
Weinberg Jonathan
General Counsel
Transactions
- Award
Class A Common Stock
2025-07-01+23,394→ 254,179 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. Weinberg pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028.
- [F3]Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting.
- [F4]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001642833
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 7:10 AM ET
- Size
- 5.8 KB